Courier Capital’s Quest Diagnostics DGX Stock Holding History

Courier Capital’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$815K	Hold	3,844	–	–	0.04%	233
2026 Q1	$753K	Hold	3,844	–	–	0.04%	234
2025 Q4	$667K	Sell	3,844 -1,100	-22%	-$200K	0.04%	239
2025 Q3	$942K	Hold	4,944	–	–	0.05%	221
2025 Q2	$888K	Sell	4,944 -55	-1%	-$9.55K	0.05%	217
2025 Q1	$846K	Hold	4,999	–	–	0.06%	214
2024 Q4	$754K	Hold	4,999	–	–	0.05%	218
2024 Q3	$776K	Buy	4,999 +1,420	+40%	+$212K	0.05%	209
2024 Q2	$490K	Hold	3,579	–	–	0.04%	230
2024 Q1	$476K	Hold	3,579	–	–	0.03%	247
2023 Q4	$493K	Hold	3,579	–	–	0.04%	239
2023 Q3	$436K	Sell	3,579 -45	-1%	-$6K	0.04%	249
2023 Q2	$509K	Sell	3,624 -300	-8%	-$41.4K	0.04%	238
2023 Q1	$555K	Hold	3,924	–	–	0.06%	164
2022 Q4	$614K	Hold	3,924	–	–	0.07%	154
2022 Q3	$481K	Hold	3,924	–	–	0.06%	170
2022 Q2	$522K	Hold	3,924	–	–	0.06%	167
2022 Q1	$537K	Sell	3,924 -29	-0.7%	-$4.04K	0.05%	174
2021 Q4	$684K	Hold	3,953	–	–	0.06%	163
2021 Q3	$574K	Hold	3,953	–	–	0.05%	173
2021 Q2	$522K	Sell	3,953 -9	-0.2%	-$1.18K	0.05%	186
2021 Q1	$509K	Hold	3,962	–	–	0.05%	180
2020 Q4	$472K	Hold	3,962	–	–	0.05%	178
2020 Q3	$503K	Sell	3,962 -200	-5%	-$23.6K	0.06%	164
2020 Q2	$483K	Buy	4,162 +28	+0.7%	+$2.97K	0.06%	165
2020 Q1	$390K	Hold	4,134	–	–	0.06%	170
2019 Q4	$439K	Hold	4,134	–	–	0.05%	183
2019 Q3	$428K	Hold	4,134	–	–	0.06%	182
2019 Q2	$421K	Hold	4,134	–	–	0.05%	181
2019 Q1	$372K	Hold	4,134	–	–	0.05%	193
2018 Q4	$344K	Hold	4,134	–	–	0.05%	185
2018 Q3	$446K	Hold	4,134	–	–	0.05%	172
2018 Q2	$454K	Hold	4,134	–	–	0.06%	179
2018 Q1	$415K	Hold	4,134	–	–	0.05%	184
2017 Q4	$407K	Hold	4,134	–	–	0.05%	187
2017 Q3	$387K	Hold	4,134	–	–	0.05%	176
2017 Q2	$460K	Hold	4,134	–	–	0.08%	155
2017 Q1	$406K	Hold	4,134	–	–	0.07%	168
2016 Q4	$380K	Hold	4,134	–	–	0.07%	171
2016 Q3	$350K	Hold	4,134	–	–	0.07%	193
2016 Q2	$337K	Hold	4,134	–	–	0.07%	205
2016 Q1	$295K	Hold	4,134	–	–	0.06%	214
2015 Q4	$294K	Sell	4,134 -100	-2%	-$6.72K	0.06%	210
2015 Q3	$260K	Buy	4,234 +100	+2%	+$6.99K	0.06%	214
2015 Q2	$300K	Buy	4,134 +10	+0.2%	+$738	0.06%	204
2015 Q1	$317K	Hold	4,124	–	–	0.06%	202
2014 Q4	$277K	Hold	4,124	–	–	0.06%	222
2014 Q3	$250K	Buy	4,124 +300	+8%	+$18.5K	0.05%	231
2014 Q2	$224K	Hold	3,824	–	–	0.04%	254
2014 Q1	$221K	Hold	3,824	–	–	0.05%	255
2013 Q4	$205K	Hold	3,824	–	–	0.04%	262
2013 Q3	$236K	Hold	3,824	–	–	0.05%	236
2013 Q2	$232K	Buy	+3,824	New	+$228K	0.06%	237

Other funds holding DGX

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return

CPC

Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return

AIM

Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

AAIS

ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Courier Capital's DGX Position: Q2 2026 in Review

Courier Capital held its Quest Diagnostics (DGX) position steady in Q2 2026 at 3,844 shares worth $815K. The position accounts for 0.04% of the portfolio, ranked #233.

Courier Capital first reported a position in DGX in Q2 2013 and has held it in 53 quarters since. The position peaked at $942K in Q3 2025. 443 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Courier Capital held 3,844 shares of Quest Diagnostics worth $815K as of Q2 2026.
Courier Capital left its Quest Diagnostics share count unchanged in Q2 2026.
Quest Diagnostics made up 0.04% of Courier Capital's portfolio in Q2 2026, its #233 holding.
Courier Capital first reported a position in Quest Diagnostics in Q2 2013 and has held it in 53 quarters since.
Courier Capital's Quest Diagnostics position peaked at $942K in Q3 2025.
443 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Courier Capital's 13F filing for Q2 2026, filed 16 Jul 2026.